How You Can Help


Donate

PharmedOut welcomes gifts to support and advance its innovative educational programs and research initiatives. Gifts and grants provide valuable resources to launch new physician education programs and research projects assessing drug industry marketing strategies. Your generous support will make a difference.

Checks should be made out to Georgetown University. Please designate PharmedOut in the memo section of your check or in accompanying correspondence and mail to the address below.

Credit card contributions can be made by phone at 202-687-4900 or via internet (choose "other" for designation and write "PharmedOut" under special designation).

We also welcome gifts of securities, real estate and other appreciated property, as well as bequests. For further information, please contact Sandra Lovinguth at lovingus@georgetown.edu.

Georgetown University
Office of Medical Center Advancement
Box 571404
Washington, DC 20057-1404
202-687-4900

All gifts benefit the PharmedOut project at Georgetown University and are tax-deductible to the full extent specified by the law.

Invite PharmedOut Physicians to Lecture

Lecture Topics

Contact Us


Our Videos



Pharma Insider II
Opposition research
(read transcript)


Pharma Insider I
Off-label promotion under the radar
(read transcript)

The Art of Medical Writing
Pharma's anonymous writers

Drug Reps Talk Shop II
Drug reps continue their chat

Drug Reps Talk Shop I Selling drugs to docs

Director of PharmedOut Explains the Project

Zyprexa Drug Rep Tells All Shahram Ahari describes how he sold the drug
News

Drug Firms Turn to Private Docs to Promote Products
University ethics policies tightened Milwaukee Journal Sentinel
J&J Pushed Risperdal After Warning, Files Show
FDA ignored; CME supported off-label uses Bloomberg
NIH Should Disclose Financial Conflicts
Public database requested Pharmalot
Diabetes Heart Treatments May Cause Harm
Normalizing BP and postprandial hyperglycemia don't help NYT
Grassley Tells PBMs To Disclose Ties To Pharma
Drugmakers may provide financial benefits Pharmalot
Analysis Finds Vioxx's Heart Attack Risk in 2001
35% increase in CV events WSJ
States, Consumer Advocates Challenge Rx Data Mining
FDA has been silent Chicago Tribune
Researcher Seeks New Treatments in Old Drugs
Bioinformatics promising Houston Chronicle
Some Doctors Say No More Free Lunches
“Goodies” are a conflict of interest Rapid City Journal
Study Raises Questions About Cholesterol Drug’s Benefit
Niacin bests Zetia NYT
Drug Makers Raise Prices in Face of Health Care Reform
Wholesale prices up 9% NYT
Commentary

Mammography and the Corporate Breast
Conflicts of USPSTF critics not mentioned Bioethics Forum
Click HERE to read the entire news archives
All content on this site is © 2006 by PharmedOut * (p) 202-687-1191 * (f) 202-687-7407 * Georgetown University
Department of Physiology and Biophysics * Box 571460 * Washington, DC 20057-1460